Riverview Trust CO Kura Oncology, Inc. Transaction History
Riverview Trust CO
- $108 Million
- Q4 2024
A detailed history of Riverview Trust CO transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Riverview Trust CO holds 2,151 shares of KURA stock, worth $17,810. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,151Holding current value
$17,810% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
196Shares Held
79.6MCall Options Held
98.7KPut Options Held
70.1K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$48 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...